The Technology

Weight-Loss Drug Users Report Mysterious 'Flatness' and Apathy

via Vox·Feb 16

As GLP-1 weight-loss drug usage has more than doubled since 2024, a concerning psychological side effect is emerging: extreme apathy. Clinical psychologist Dr. Sera Lavelle reports patients experiencing a 'missing spark,' losing interest in previously loved activities without clinical depression. The drugs may dampen dopamine and motivation-seeking behavior beyond just food cravings, affecting gambling, shopping, and even positive life experiences. While GLP-1s offer hope for those struggling with obesity and binge eating, experts warn about the nuanced mental health impacts that extend far beyond appetite suppression.

Read Full Story at Vox

Keep thy heart with all diligence; for out of it are the issues of life.

Proverbs 4:23

God's instruction to guard our hearts reminds us that pharmaceutical solutions, while potentially helpful, can never substitute for the fullness of life found in purposeful engagement with God's design for human flourishing.

HealthScience

Related Stories

RFK Jr.'s Anti-Vaccine Policies Are 'Unreviewable,' DOJ Lawyer Tells Federal Judge in Stunning Claim

Ars Technica·3d ago

Gene-Targeting Therapy Delivers Stunning 91 Percent Seizure Reduction in Children With Rare Epilepsy

ScienceDaily·3d ago

Pregnant Women Cut Tylenol Use in ERs After Trump's Unproven Autism Warning, Lancet Study Finds

Washington Times·3d ago

The Lancet Blasts RFK Jr.'s Health Record as 'a Failure' in Scathing Editorial

Ars Technica·6d ago
DiscussSoon
← Front Page